Recombinant humanized anti-PD-1 monoclonal antibody toripalimab in patients with refractory/metastatic urothelial carcinoma: Preliminary results of an open-label phase II clinical study

• H. Chen,
• X. Sheng,
• R. Zhang,
• B. Hu,
• X. Yao,
• Z. Liu,
• X. Yao,
• H. Guo,
• Y. Hu,
• Z. Ji,
• H. Luo,
• B. Shi,
• J. Liu,
• J. Wu,
• F. Zhou,
• Z. He,
• Y. Huang,
• J. Guo

Affiliations

H. Chen

X. Sheng

R. Zhang

B. Hu

X. Yao

Z. Liu

X. Yao

H. Guo

Y. Hu

Z. Ji

H. Luo

B. Shi

J. Liu

J. Wu

F. Zhou

Z. He

Y. Huang

J. Guo